The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dom.12267PMID 24460896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.

  2014cited by this paper
• Metformin use and endometrial cancer survival.

  2014cited by this paper
• Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma

  2014cited by this paper
• Effect of metformin on prostate cancer outcomes after radical prostatectomy.

  2014cited by this paper
• Metformin is associated with improved survival in endometrial cancer.

  2014cited by this paper
• Metformin reduces recurrence and improves survival in endometrial cancers

  2013cited by this paper
• Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes

  2013cited by this paper
• Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database

  2013cited by this paper
• Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.

  2013cited by this paper
• Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects.

  2013cited by this paper
• A Cohort Study of Metformin Exposure and Survival in Patients with Stage I–III Colorectal Cancer

  2013cited by this paper
• Metformin intake is associated with better survival in ovarian cancer: A case-control study

  2013cited by this paper
• Diabetes, metformin use, and colorectal cancer survival in postmenopausal women.

  2013cited by this paper
• Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors.

  2013cited by this paper
• Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer

  2013cited by this paper
• Association Between Metformin Therapy and Mortality After Breast Cancer

  2013cited by this paper
• Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.

  2013cited by this paper
• Use of Metformin and Survival of Diabetic Women with Breast Cancer

  2013cited by this paper
• Clinical Outcomes of Chemotherapy for Diabetic and Nondiabetic Patients With Pancreatic Cancer: Better Prognosis With Statin Use in Diabetic Patients

  2013cited by this paper
• Metformin and Survival in Pancreatic Cancer: A Retrospective Cohort Study

  2013cited by this paper
• The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus

  2012cited by this paper
• Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer

  2012cited by this paper
• Mortality After Incident Cancer in People With and Without Type 2 Diabetes

  2012cited by this paper
• Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

  2012cited by this paper
• The effect of metformin and thiazolidinedione use on lung cancer in diabetics

  2012cited by this paper
• Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

  2012cited by this paper
• Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.

  2012cited by this paper
• Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

  2012cited by this paper
• Metformin intake is associated with better survival in ovarian cancer

  2012cited by this paper
• MortalityAfter Incident Cancer in People With andWithout Type 2 Diabetes Impact of metformin on survival

  2012influential reference
• Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer

  2012cited by this paper
• Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes

  2011cited by this paper
• Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

  2011cited by this paper
• Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation

  2011cited by this paper
• Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

  2011cited by this paper
• Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase.

  2010cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper

• Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis

  2025cites this paper
• Metformin to treat breast cancer: An application of the prevalent new-user design for observational studies with no active comparator.

  2025cites this paper
• The effects of hsa-mir-26a-5p on cell proliferation, migration, and PI3K inhibitor sensitivity in metformin-resistant triple negative breast cancer cells

  2025cites this paper
• Drug Repurposing in Veterinary Oncology: Myth or Reality?

  2025cites this paper
• Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial

  2025cites this paper
• Characteristics of the Causes of Death in Patients with Diabetes Mellitus Receiving Recent Standard Medical Care: A Retrospective Observational Study Comparing with Non-Diabetes Patients over the Last 10 Years

  2025cites this paper
• Targeting estrogen-related receptors to mitigate tumor resistance: A comprehensive approach to bridging cellular energy metabolism.

  2024cites this paper
• Drug Repositioning for Ovarian Cancer Treatment: An Update.

  2024cites this paper
• Repurposing Metformin in hematologic tumor: State of art.

  2023cites this paper
• Low BMI patients with advanced EGFR mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trial

  2023cites this paper
• Bidirectional pharmacokinetic drug interactions between olaparib and metformin

  2023cites this paper
• Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review

  2023cites this paper
• Metformin and long non-coding RNAs in breast cancer

  2023cites this paper
• Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies

  2023cites this paper
• Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes

  2023cites this paper
• Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study

  2022cites this paper
• Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents

  2022cites this paper
• Diabetes mellitus and multiple myeloma; common features of two distinct entities

  2022cites this paper
• First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors

  2022cites this paper
• Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?

  2022cites this paper
• A ROS/Akt/NF-κB Signaling Cascade Mediates Epidermal Growth Factor-Induced Epithelial-Mesenchymal Transition and Invasion in Human Breast Cancer Cells

  2022cites this paper
• The Epigenetic Correlation among Ovarian Cancer, Endometriosis and PCOS: A Review.

  2022cites this paper
• Integrative Approaches to the Treatment of Cancer

  2022cites this paper
• Type 2 diabetes mellitus and risk of head and neck cancer subtypes: a systematic review and meta-analysis of observational studies

  2021cites this paper
• Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?

  2021cites this paper
• Perspectives of metformin use in endometrial cancer and other gynaecological malignancies

  2021cites this paper
• The Role of Metformin in Ovarian Cancer: Does Metformin Increase Survival in Ovarian Neoplasm?

  2021cites this paper
• Metformin Adjunct With Antineoplastic Agents for the Treatment of Lung Cancer: A Meta-Analysis of Randomized Controlled Trials and Observational Cohort Studies

  2021cites this paper
• A systematic review and meta-analysis on the efficacy and safety of metformin as adjunctive therapy among women with metastatic breast cancer.

  2021cites this paper
• Metformin improves survival in patients with concurrent diabetes and small cell lung cancer: a meta-analysis.

  2021cites this paper
• Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer

  2020cites this paper
• Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review

  2020cites this paper
• Molecular Targeted Therapy in Endometrial Cancer: Basis and Therapeutics

  2020cites this paper
• Immunohistochemical expression of insulin-like growth factor-1Ec in primary endometrial carcinoma: Association with PTEN, p53 and survivin expression

  2020cites this paper
• Recycling the Purpose of Old Drugs to Treat Ovarian Cancer

  2020cites this paper
• Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis

  2020cites this paper
• Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma

  2020cites this paper
• Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status

  2020cites this paper
• Recent Advances in Endometrial Cancer

  2020cites this paper
• Associations between metabolic syndrome and gynecologic cancer

  2020cites this paper
• 二甲双胍抗肺癌机制研究进展

  2020cites this paper
• Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.

  2020cites this paper
• Repurposing old drugs to fight multidrug resistant cancers.

  2020cites this paper
• Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?

  2020cites this paper
• The association between metformin and head and neck cancer survival: a systematic review and meta-analysis of cohort studies.

  2020cites this paper
• Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-Blind Placebo-Controlled Trial

  2020cites this paper
• Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus

  2020cites this paper
• The anti-proliferative role of metformin in non-diabetic female patients with breast cancer: systematic review and meta-analysis of randomized control trials

  2020cites this paper
• The association between metformin and ovarian cancer survival: a systematic review and meta-analysis of cohort studies.

  2019cites this paper
• Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial

  2019cites this paper
• Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility

  2019cites this paper
• Association between diabetes and oncological outcomes in patients undergoing neoadjuvant chemo-radiotherapy for rectal cancer.

  2019cites this paper
• Different trends in colorectal cancer mortality between age groups in China: an age-period-cohort and joinpoint analysis.

  2019cites this paper
• Drug Repositioning in Oncology.

  2019cites this paper
• Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis

  2019cites this paper
• Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China

  2019cites this paper
• Effect of metformin use on the risk and prognosis of ovarian cancer: an updated systematic review and meta-analysis.

  2019cites this paper
• Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: A Joinpoint and Age-Period-Cohort Analysis

  2019cites this paper
• METFORMIN AND DICHOLOROACETATE COMBINATION EXERT A SYNERGISTIC EFFECT ON CELL VIABILITY OF ORAL SQUAMOUS CELL CARCINOMA

  2019cites this paper
• Androgen Receptor and PI3K Pathway Activity in Ovarian Cancer

  2019cites this paper
• The effect of metformin on biomarkers and survivals for breast cancer‐ a systematic review and meta‐analysis of randomized clinical trials

  2019cites this paper
• Secular trends in incidence and mortality of bladder cancer in China, 1990-2017: A joinpoint and age-period-cohort analysis.

  2019cites this paper
• Metformin and pancreatic cancer survival: Real effect or immortal time bias?

  2019influential citation
• Observational Studies on the Association Between Post-diagnostic Metformin Use and Survival in Ovarian Cancer: A Systematic Review and Meta-Analysis

  2019cites this paper
• Metformin as an adjuvant in breast cancer treatment

  2019cites this paper
• Does diabetes decrease the risk of glioma? A systematic review and meta-analysis of observational studies.

  2019cites this paper
• Antiproliferative and antiangiogenic effects of metformin on multidrug-resistant MCF-7 cells

  2018cites this paper
• Mechanisms Linking Obesity and Thyroid Cancer Development and Progression in Mouse Models

  2018cites this paper
• Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation

  2018cites this paper
• Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register‐based study

  2018cites this paper
• Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P‐gp‐overexpressing MCF‐7 cells

  2018cites this paper
• Pre-Menopause, Menopause and Beyond

  2018influential citation
• Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis

  2018cites this paper
• Metformin as a Therapeutic Target in Endometrial Cancers

  2018cites this paper
• Metformin and blood cancers

  2018cites this paper
• Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis

  2018cites this paper
• SPARC Inhibits Metabolic Plasticity in Ovarian Cancer

  2018cites this paper
• Glucose Deprivation Enhances the Antiproliferative Effects of Oral Hypoglycemic Biguanides in Different Molecular Subtypes of Breast Cancer: an in Vitro Study

  2018cites this paper
• Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China

  2018cites this paper
• Obesity, Metabolic Syndrome, and Breast Cancer: From Prevention to Intervention

  2018cites this paper
• Why Metformin Is so Important for Prevention and Therapy in Climacteric Women

  2018cites this paper
• Metformin and Prostate Cancer: A New Era of s Prostate Cancer Research

  2018cites this paper
• Repurposing medicines for the adjuvant treatment of cancer: An evaluation of aspirin and metformin

  2018cites this paper
• Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.

  2017cites this paper
• Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

  2017cites this paper
• Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies

  2017cites this paper
• Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.

  2017cites this paper
• Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis.

  2017cites this paper
• Erratum to: The need for differentiating diabetes-specific mortality from total mortality when comparing metformin with insulin regarding cancer survival

  2017cites this paper
• Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.

  2017influential citation
• Metformin – the newer role of the old medicine - in cancer prevention and treatment!

  2017cites this paper
• Repurposing metformin for the prevention of cancer and cancer recurrence

  2017cites this paper
• Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients

  2017cites this paper
• Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?

  2017cites this paper
• Insulin use, adipokine profiles and breast cancer prognosis

  2017cites this paper
• Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients

  2017cites this paper
• Metformin and endometrial cancer survival: a quantitative synthesis of observational studies

  2017cites this paper
• Inositol(s) from Bench to Bedside in Endocrinology and Gynecology

  2017cites this paper
• NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo

  2016cites this paper
• Update on immune checkpoint inhibitors in gynecological cancers

  2016cites this paper